Polycystic
ovarian syndrome is a common endocrine disorder in reproductive age, with
unknown etiology and a variable clinical presentation.
Recognizing polycystic
ovary syndrome in women presenting with oligo-ovulation and
hyperandrogenism offers an important opportunity to begin a life-long
conversation about prevention and treatment of a condition that has a
multi-system impact on affected women.
Recognition
offers the chance for providers and patients to engage in discussions about
prevention and early treatment of metabolic derangements.
